Alzheimer's disease: An estrogen link?

Current Opinion in Obstetrics and Gynecology

Volumn 9, Issue 5, 1997, Pages 295-299

  Beckmann, Charles R B ^a  

^a TRUMAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ALZHEIMER DISEASE; DISEASE ASSOCIATION; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0030820492     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199710000-00004     Document Type: Review

References (76)

1. Aizheimer A: About a peculiar disease of the cerebral cortex. Llegneime Z Psychiatr Psychish-Gerichtliche Med 1907, 64:146-148.
2. Bachman DI, Wolf PA, Linn R et al.: Prevalence of dementia and probably senile dementia of the Aizheimer type in the Framingham study. Neurology 1992, 42:115-119.
3. Joram AB, Korten AE, Henderson AS: The prevalence of dementia: a quantitative integration of the literature. Ada Psychiatr Scand 1987, 76:465-475.
4. Heyman A, Peterson B, Fillenbum G et al.: CERAD, Part XIV. Demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology 1996, 46:656-600.
5. Molsa PK, Marttila RJ, Rinne UK: Epidemiology of dementia in a Finnish population. Acta Neurol Scand 1982, 656:541-552.
6. Hay JW, Ernst RI: The economic costs of Alzheimer's disease. Am J Public Health 1987, 77:1169-1175.
7. Heyman A, Wilkinson WE, Stafford JA et al.: Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984, 15:335-341.
8. Keefover RW: The clinical epidemiology of Alzheimer's disease. Neurol Clin 1996, 14:337-351. An excellent review of the current understanding of AD.
9. Cohn D, Eisdorfer C, Gorelick P et al.: Sex differences in the psychiatric manifestations of Alzheimer's disease. J Am Geriatr Soc 1993, 41:229-232.
10. Filley CM: Alzheimer's disease in women. Am J Obstet Gynecol 1997, 1:1-7. An overview of the impact and epidemiology, theories of cause, pathophysiology, and therapy for Alzheimer's disease from the obstetrics and gynecology/primary care perspectives.
11. McKhann G, Drachman D, Folstein M et al.: Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-945.
12. Wisniewski KE, Dalton AJ, McLachlan DR et al.: Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology 1985, 35:957-961.
13. St George-Hyslop PH, Tanzi RE, Polinsky RJ et al.: The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987, 235:885-890.
14. Levy-Lahad E, Wijsman EM, Nemens E et al.: A familial Alzheimer's disease locus on chromosome 1. Science 1995, 269:970-973
15. Schellenberg GD, Bird TD, Wijsman EM et al.: Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992, 258:668-671.
16. Roses AD: Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995, 39:6-14.
17. Honjo H, Tanaka K, Kashiwagi T, Urabe M, Okada H, Hayashi M, Hayashi K: Senile dementia-Alzheimer's type and estrogen. Horm Metab Res 1995, 27:204-207.
18. National Institute on Aging/Alzheimer's Association Working Group: Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996, 347:1091-1095.
19. Reiman EM, Caselli RJ, Yun LS et al.: Preclinical evidence of Alzheimer's disease in persons homozygous for the E4 allele for apolipoprotein E. N Engl J Med 1996, 334:752-758.
20. Parker WD, Filley CM, Parks J: Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 1990, 40:1302-1303.
21. Parker WD, Parks J, Filley CM et al.: Electron transport chain defects in Alzheimer's disease brain. Neurology 1994, 44:1086-1089.
22. Clark RF, Goate AM: Molecular genetics of Alzheimer's disease. Aren Neurol 1993, 50:1164-1172.
23. Jaffe AB, Toran-Allerand CD, Greengard P et al.: Estrogen regulates metabolism of Alzheimer's amyloid beta precursor protein. J Biol Chem 1994, 269:13065-13068.
24. Bartus RT, Dean RL, Beer B, Lippa AS: The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-414.
25. Gomez-Vargas M, Ogawa N: Clinical applications of neurotransmitter-receptor studies in geriatric neuropharmacology. Acta Med Okayama 1996, 50:173-190.
26. Whitehouse PH, Price DL, Stuble RG et al.: Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982, 215:1237-1239.
27. Luine VN, Khylchevskaya RI, McEwen B: Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res 1975, 86:293-306.
28. Stumpf WE, Sar M: Steroid hormone target sites in the brain: the differential distribution of estrogen, progestin, androgen and glucocorticoid. J Steroid Biochem 1976, 7:1163-1170.
29. Matsumoto A, Arai Y, Osanai M: Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats. Neurosci Res 1985, 2:412-418.
30. Arimatsu Y, Hatamaka H: Estrogen treatment enhances survival of cultured amygdala neurons in a defined medium. Dev Brain Res 1986, 26:151-159.
31. Matsumoto A: Synaptogenic action of sex steroids in developing and adult neuroendocrine brain. Psychoneuroendocrinology 1991, 16:25-40.
32. Birge SJ: The role of estrogen deficiency in the aging central nervous system. In Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. Edited by Lobo R. Philadelphia: Lippincott; 1996:153-157. A clearly written exposition of current understanding of the relationship of endogenous estrogen status, ERT, and dementia of the Alzheimer's type.
33. Toran-Allerand CD, Miranda RC, Bentham WDL et al.: Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 1992, 89:4668-4672.
34. Barrett-Connor E, Kritz-Silberstein D: Estrogen replacement therapy and cognitive function in older women. JAMA 1993, 260:2637-2641.
35. Klaiber EL, Broverman DM, Vogel W et al.: Estrogen replacement therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979, 36:550-554.
36. Phillips SM, Sherwin BB: Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992, 17:485-495.
37. Sherwin BB: Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988, 14:177-187.
38. Sherwin BB, Gelfand MM: A prospective one year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids. Obstet Gynecol 1989, 73:759-766.
39. Sherwin BB: Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996, 87:20S-26S.
40. Ohkura T, Teshima Y, Isse K et al.: Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause 1995, 2:13-18.
41. Eberling JL, Jagust WJ, Reed B et al.: Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging 1992, 13:483-491.
42. O'Brien MD: How does cerebrovascular disease cause dementia? Dementia 1994, 5:133-136.
43. Zhang WW, Badonic T, Hoog A et al.: Structural and vasoactive factors influencing intracerebral arterioles in cases of vascular dementia and other cerebrovascular disease: a review. Dementia 1994, 5:153-162.
44. Birge S: Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 1996, 44:865-870. A clear review of the issues regarding estrogen/estrogen replacement and AD, with specific reference to management issues.
45. Broe GA, Henderson AS, Ceasy H et al.: A case-control study of Alzheimer's disease in Australia. Neurology 1990, 40:1698-1707.
46. Buchwalter JG, Sobel E, Dunn ME et al.: Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Arch Neural 1993, 50:757-760.
47. Henderson V, Buchwalter JG: Cognitive deficits of men and women with Alzheimer's disease. Neurology 1994, 44:90-96.
48. Ripich DN, Petrill SA, Whitehouse PJ et al.: Gender differences in language of AD patients: a longitudinal study. Neurology 1995, 45:299-302.
49. Berlinger WG, Porter JF: Lower body mass index in demented outpatients. J Am Geriatr Soc 1991, 39:973-978.
50. Buckwalter JG, Schneider L, Dunn M et al.: Higher body weight is associated with better cognitive performance in women with probable Alzheimer's disease [Abstract]. Neurology 1994, 44 (suppl 2):A186.
51. Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ: Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology 1996, 46:1585-1591.
52. Meldrum DR, Davidson BJ, Tataryn IV et al.: Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 1981, 57:624-628.
53. Paganini-Hill A, Henderson VW: Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994, 140:256-261.
54. Behl C, Widmann M, Trapp T, Holsboer F: 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995, 216:473-482.
55. Luine VN, Park D, Joh T et al.: Immunochemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estradiol administration. Brain Res 1980, 191:273-277.
56. Luine VN: Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985, 89:484-490.
57. Simplins J, Singh M, Bishop J: The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging 1994, 15:3195-5197.
58. Singh M, Meyer EM, Simplins JW: The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 1995, 136:2320-2324.
59. Amaducci LA, Fratiglioni L, Rocca WA et al.: Risk factors for clinically diagnosed Alzheimer's disease: a case control study of an Italian population. Neurology 1986, 36:922-931.
60. Campbell S, Whitehead M: Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977, 64:31-47.
61. Graves AB, White E, Koepsell TD et al.: A case control study of Alzheimer's disease. Ann Neurol 1990, 28:766-774.
62. Henderson V, Paganini-Hill A, Emanual CK, Dunn ME, Buekwalter JG: Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 1994, 51:896-900.
63. Fedor-Freybergh P: The influence of oestrogen on the well being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand 1977, 64:50-69.
64. Fillit H, Weiinreb H, Cholst I et al.: Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 1986, 11:337-345.
65. Honjo H, Ogino Y, Naitok K et al.: In vivo effects by estrone sulfate on central nervous system-senile dementia (Alzheimer's type). J Steroid Biochem 1989, 34:521-525.
66. Schneider MA, Brotherton PL, Halles J: The effect of exogenous oestrogens on depression in menopausal women. Med J Aust 1977, 2:162-163.
67. Sherwin BB: Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988, 13:345-357.
68. Henderson V, Watt L, Buekwalter J: Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 1996, 21:421-430.
69. Paganini-Hill A: Oestrogen replacement therapy and Alzheimer's disease. Br J Obstet Gynaecol 1996, 103:80-86.
70. Paganini-Hill A, Henderson V: Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med 1996, 156:2213-2217.
71. Tang M, Jacobs D, Stern Y, Marder K, Schofield P, Garland B, Andrews H, Mayeux R: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996, 348:429-432.
72. Kawas C, Resnick S, Morrison A et al.: A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997, 48:1517-1521.
73. Brenner DE, Kukull WA, Stergachis A, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB: Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol 1994, 140:262-267.
74. Schneider LS, Farlow MR, Henderson VW, Pogoda JM: Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996, 46:1580-1584.
75. Marx J: Searching for drugs that combat Alzheimer's. Science 1996, 273:50-53.
76. Kuller L: Hormone replacement therapy and its potential relationship to dementia. J Am Geriatr Soc 1996, 44:878-880. A clear and comprehensive review of the issues regarding estrogen, ERT and dementia of the Alzheimer's type from the gerontologic perspective.